MiMedx Audit Committee Tries To Avoid Criticism
Background of the Investigation
Flaws in Revenue Recognition Allegations
MiMedx Continues to Fight Against Holding Annual Meeting
Response to MiMedx Allegations Against Former Management
MiMedx Shareholder Group Calls Out Significant Drop In Profitability
MiMedx Shareholder Group Responds to MiMedx Press Release April 11th
Cardiac Arrest - Five Heart-Stopping Years as a CEO on the Feds' Hit-List
Former Vascular Solutions CEO Howard Root Talks About DOJ's Culture of Prosecution
Sally Yates's Legacy of Injustice at the Department of Justice
Gagged: Feds Use Criminal Charges, Threats to Silence Drugmakers
Enter The Senators: The Howard Root Saga Continues!
Sally Yates Legacy of Injustice at the DOJ
The Yates Memo: Looking for "Individual Accountability" in All the Wrong Places
Press Release on SEC Dismissal.pdf
Board Applauds Dismissal of Lawsuit.pdf
WSJ Article Setbacks Show Holes in Insider-Trading Cases.pdf
Illegal Short Selling Against MiMedx
Cohodes Illegal Selling Operations
Publication by MiMedx Group, Inc.
How NOT to Do Investigative Journalism
Fraser Perring: Chronicles of Deceit, Part One
How Shorts Went Wrong on Health Insurance Innovations and MiMedX
Please see www.mimedxboardproxy.com for further information. Due to initiatives by Pete Petit and others, four of the original eight outside board members are no longer in those positions. Other board changes will occur at the 2019 and 2020 shareholder meetings.
April 3rd Court Hearing on Shareholder Meeting
SEC Charges The Hain Celestial Group with Internal Controls Failures